The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment.
Saved in:
| Title: | The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment. |
|---|---|
| Authors: | Chan NSL; Centre for Pharmaceutical Innovation, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Cross C; School of Biomedicine, University of Adelaide, Adelaide, South Australia, Australia.; Precision Medicine (Cancer), South Australian Health and Medical Research Institute SAHMRI, University of Adelaide, Adelaide, South Australia, Australia., Prestidge CA; Centre for Pharmaceutical Innovation, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Wardill HR; School of Biomedicine, University of Adelaide, Adelaide, South Australia, Australia.; Precision Medicine (Cancer), South Australian Health and Medical Research Institute SAHMRI, University of Adelaide, Adelaide, South Australia, Australia., Bowen J; School of Biomedicine, University of Adelaide, Adelaide, South Australia, Australia., Joyce P; Centre for Pharmaceutical Innovation, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, South Australia, Australia. |
| Source: | Critical reviews in microbiology [Crit Rev Microbiol] 2026 Jan 01, pp. 1-18. Date of Electronic Publication: 2026 Jan 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914274 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-7828 (Electronic) Linking ISSN: 1040841X NLM ISO Abbreviation: Crit Rev Microbiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
